OncoCyte to Report Second Quarter 2018 Financial Results on August 14, 2018
30 juil. 2018 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, announced...
OncoCyte Announces At-Market $3.59 Million Offering of Common Stock and Warrants
27 juil. 2018 09h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., July 27, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of cancer,...
OncoCyte Reports Encouraging New Study Results for Lung Cancer Blood Test
09 juil. 2018 16h10 HE
|
OncoCyte Corporation
- Results suggest improved performance of next-generation test- Study results support move to new diagnostic testing platform- Significant development work required to fully validate this recent...
OncoCyte Reports First Quarter 2018 Financial Results
15 mai 2018 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive tests for the early detection of cancer, today reported financial and...
OncoCyte to Report First Quarter 2018 Financial Results on May 15, 2018
08 mai 2018 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif, May 08, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, announced today...
Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCyte’s Board of Directors
03 avr. 2018 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX) today announced the appointment of Ronald Andrews, Jr., an executive with over 30 years’ experience in...
OncoCyte Reports Fourth Quarter and Full Year 2017 Financial Results
02 avr. 2018 16h12 HE
|
OncoCyte Corporation
Development of DetermaVu™ Remains on Track for Completion in 2018 -Conference Call Today at 4:30 pm ET- ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE...
OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers
02 avr. 2018 16h10 HE
|
OncoCyte Corporation
ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy diagnostic tests for the early detection of...
OncoCyte Names Cavan Redmond Chairman of the Board of Directors
02 avr. 2018 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX) today announced that Cavan Redmond, a director of the Company since 2015, has been named Chairman of the...
OncoCyte to Report Fourth Quarter and Full Year 2017 Financial Results on April 2, 2018
29 mars 2018 07h00 HE
|
OncoCyte Corporation
ALAMEDA, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American:OCX), a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, announced...